News
Q3/2024 Life Science Law Update – Key developments for pharma & device companies in EU
31 October 2024
We establish regulatory training programs to educate internal units of major medical device and combination product companies about adverse event reporting requirements and procedures.
We have assisted clients in responding to enforcement actions related to inadequate adverse event reporting and helped develop procedures to protect against future enforcement.
Helped clients conduct retrospective reviews of their files to assess their obligations in submitting Medical Device Reports to the FDA and bring their reporting up to date.